全文获取类型
收费全文 | 1644篇 |
免费 | 103篇 |
国内免费 | 64篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 44篇 |
妇产科学 | 24篇 |
基础医学 | 208篇 |
口腔科学 | 13篇 |
临床医学 | 232篇 |
内科学 | 353篇 |
皮肤病学 | 24篇 |
神经病学 | 124篇 |
特种医学 | 57篇 |
外科学 | 370篇 |
综合类 | 4篇 |
预防医学 | 83篇 |
眼科学 | 27篇 |
药学 | 72篇 |
肿瘤学 | 131篇 |
出版年
2023年 | 14篇 |
2022年 | 29篇 |
2021年 | 75篇 |
2020年 | 32篇 |
2019年 | 50篇 |
2018年 | 65篇 |
2017年 | 36篇 |
2016年 | 42篇 |
2015年 | 39篇 |
2014年 | 60篇 |
2013年 | 68篇 |
2012年 | 112篇 |
2011年 | 93篇 |
2010年 | 59篇 |
2009年 | 35篇 |
2008年 | 72篇 |
2007年 | 93篇 |
2006年 | 79篇 |
2005年 | 63篇 |
2004年 | 58篇 |
2003年 | 56篇 |
2002年 | 53篇 |
2001年 | 59篇 |
2000年 | 39篇 |
1999年 | 48篇 |
1998年 | 17篇 |
1997年 | 14篇 |
1996年 | 22篇 |
1995年 | 18篇 |
1994年 | 14篇 |
1993年 | 7篇 |
1992年 | 30篇 |
1991年 | 32篇 |
1990年 | 33篇 |
1989年 | 30篇 |
1988年 | 19篇 |
1987年 | 19篇 |
1986年 | 19篇 |
1985年 | 18篇 |
1984年 | 20篇 |
1983年 | 8篇 |
1982年 | 9篇 |
1981年 | 6篇 |
1980年 | 9篇 |
1979年 | 5篇 |
1978年 | 3篇 |
1977年 | 7篇 |
1974年 | 5篇 |
1972年 | 3篇 |
1970年 | 3篇 |
排序方式: 共有1811条查询结果,搜索用时 20 毫秒
71.
72.
Aims/hypothesis. Alterations in the regulation of gene expression could be involved in the development of Type II (non-insulin-dependent) diabetes mellitus.¶Methods. We compared the mRNA concentrations of eight genes encoding proteins involved in insulin action and intermediary metabolism in skeletal muscle of healthy volunteers and Type II diabetic patients. The in vivo regulation of the expression of these genes was investigated after 5 days of hypocaloric diet (1045 kJ/day).¶Results. In the basal state, diabetic muscle showed reduced insulin receptor (–38 %), hexokinase II (–73 %), glycogen synthase (–45 %) and lipoprotein lipase (–70 %) mRNA expression. There was no difference in the mRNA abundances of IRS-1, GLUT 4, p85α phosphatidylinositol-3-kinase (p85αPI3K) or Rad. In both groups, caloric restriction induced weight loss, reduced glycaemia and increased plasma ketone body concentrations. The diet also increased plasma concentrations of fatty acids and decreased whole-body insulin sensitivity in control subjects. In control subjects, the diet increased p85αPI3K ( + 146 %), insulin receptor ( + 100 %) and Rad ( + 40 %) mRNA concentrations in muscle. In Type II diabetic patients, the diet increased insulin receptor ( + 41 %) and Rad ( + 31 %) mRNAs but the expression of p85αPI3K was not modified.¶Conclusion/interpretation. The regulation of the expression of p85αPI3K is altered during caloric restriction in skeletal muscle of Type II diabetic patients. Because we have shown in an earlier study that there is also a defective regulation of p85αPI3K gene expression in response to insulin, these data support the hypothesis that alterations in the regulation of gene expression could be involved in the pathogenesis of Type II diabetes. [Diabetologia (2000) 43: 356–363] 相似文献
73.
74.
Jenna Anderson Sara Hägglund Emmanuel Bréard Mickaël Riou Siamak Zohari Loic Comtet Ann-Sophie Olofson Robert Gélineau Guillaume Martin Marianne Elvander Gunilla Blomqvist Stéphan Zientara Jean Francois Valarcher 《Vaccine》2014
Bluetongue virus (BTV) infections in ruminants pose a permanent agricultural threat since new serotypes are constantly emerging in new locations. Clinical disease is mainly observed in sheep, but cattle were unusually affected during an outbreak of BTV seroype 8 (BTV-8) in Europe. We previously developed an experimental vaccine based on recombinant viral protein 2 (VP2) of BTV-8 and non-structural proteins 1 (NS1) and NS2 of BTV-2, mixed with an immunostimulating complex (ISCOM)–matrix adjuvant. We demonstrated that bovine immune responses induced by this vaccine were as good or superior to those induced by a classic commercial inactivated vaccine. In this study, we evaluated the protective efficacy of the experimental vaccine in cattle and, based on the detection of VP7 antibodies, assessed its DIVA compliancy following virus challenge. Two groups of BTV-seronegative calves were subcutaneously immunized twice at a 3-week interval with the subunit vaccine (n = 6) or with adjuvant alone (n = 6). Following BTV-8 challenge 3 weeks after second immunization, controls developed viremia and fever associated with other mild clinical signs of bluetongue disease, whereas vaccinated animals were clinically and virologically protected. The vaccine-induced protection was likely mediated by high virus-neutralizing antibody titers directed against VP2 and perhaps by cellular responses to NS1 and NS2. T lymphocyte responses were cross-reactive between BTV-2 and BTV-8, suggesting that NS1 and NS2 may provide the basis of an adaptable vaccine that can be varied by using VP2 of different serotypes. The detection of different levels of VP7 antibodies in vaccinated animals and controls after challenge suggested a compliancy between the vaccine and the DIVA companion test. This BTV subunit vaccine is a promising candidate that should be further evaluated and developed to protect against different serotypes. 相似文献
75.
76.
Antoine Néel Benoit Henry Sebastien Barbarot Agathe Masseau François Perrin Claire Bernier Xavier Kyndt Xavier Puechal Pierre-Jean Weiller Olivier Decaux Jacques Ninet Arnaud Hot Achille Aouba Leonardo Astudillo Jean-Marie Berthelot Fabrice Bonnet Jean-Marie Brisseau Bérangère Cador Fabienne Closs-Prophette Thomas Dejoie Jean-Dominique de Korwin Robin Dhote Renato Fior Bernard Grosbois Eric Hachulla Pierre-Yves Hatron Henry Jardel David Launay Adrien Lorleac'h Pierre Pottier Guillaume Moulis Jacques Serratrice Amar Smail Mohamed Hamidou 《Autoimmunity reviews》2014,13(10):1035-1041
The aim of this study is to assess the long-term effectiveness and safety of IL1Ra in Schnitzler syndrome (SchS). Between 2010 and 2012, we performed a nationwide survey among French internal medicine departments to identify SchS patients. We retrospectively analyzed the long-term efficacy and safety of IL1Ra and the outcome of patients that did not receive this treatment. Forty-two patients were included in the study, 29 of whom received IL1Ra. The mean age at disease onset was 59.9 years. Disease manifestations included urticaria (100%), fever (76%), bone/joint pain (86%), bone lesions (76%), anemia (67%), and weight loss (60%). The monoclonal gammopathy was overwhelmingly IgM kappa (83%). The mean follow-up was 9.5 years (range: 1.6-35). Two patients developed Waldenström's macroglobulinemia and one developed AA amyloidosis. All of the 29 patients who received IL1Ra responded dramatically. After a median follow-up of 36 months (range: 2-79), the effectiveness remained unchanged. All patients remained on anti-IL-1 therapy. Twenty-four patients (83%) went into complete remission and five (17%) into partial remission. Three patients experienced grade 3-4 neutropenia. Six patients developed severe infections. No lymphoproliferative diseases occurred while on IL1Ra. When last seen, all patients without anakinra had an active disease with variable impact on their quality of life. Their median corticosteroids dosage was 6 mg/d (range: 5-25). IL1Ra is effective in SchS, with a sharp corticosteroid-sparing effect. Treatment failures should lead to reconsider the diagnosis. Long-term follow-up revealed no loss of effectiveness and a favorable tolerance profile. The long-term effects on the risk of hemopathy remain unknown. 相似文献
77.
78.
Patients homozygous for Hb S need to be properly identified to start as early as possible a treatment that should avoid complications. For prevention and genetic counseling, carriers of Hb S have to be screened. Hb S is easily detected by several analytical systems, but other variants, usually harmless, may behave as Hb S, leading to false positive diagnosis. Some interactions may also cause difficulties in the qualitative or quantitative interpretation of a chromatography or electrophoresis profile. These problems may result from several causes among which the simultaneous presence of an α chain variant leading to the formation of tetramers having both an α and a β chain modified, the presence of a second mutation within the Hb S allele, the existence of a compound heterozygous state leading to some “Hb S trait with dominantly transmitted sickle cell disease (SCD)”, and the presence of thalassemic allele affecting the intracellular proportion of Hb S. In case of any “dominant Hb S trait” a thorough Hb study is always required. This work reports some of the difficulties observed by us, or reported in the literature, and propose how to avoid them and reach a correct diagnosis. 相似文献
79.
80.
Mergny JL Lacroix L Teulade-Fichou MP Hounsou C Guittat L Hoarau M Arimondo PB Vigneron JP Lehn JM Riou JF Garestier T Hélène C 《Proceedings of the National Academy of Sciences of the United States of America》2001,98(6):3062-3067
The reactivation of telomerase activity in most cancer cells supports the concept that telomerase is a relevant target in oncology, and telomerase inhibitors have been proposed as new potential anticancer agents. The telomeric G-rich single-stranded DNA can adopt in vitro an intramolecular quadruplex structure, which has been shown to inhibit telomerase activity. We used a fluorescence assay to identify molecules that stabilize G-quadruplexes. Intramolecular folding of an oligonucleotide with four repeats of the human telomeric sequence into a G-quadruplex structure led to fluorescence excitation energy transfer between a donor (fluorescein) and an acceptor (tetramethylrhodamine) covalently attached to the 5' and 3' ends of the oligonucleotide, respectively. The melting of the G-quadruplex was monitored in the presence of putative G-quadruplex-binding molecules by measuring the fluorescence emission of the donor. A series of compounds (pentacyclic crescent-shaped dibenzophenanthroline derivatives) was shown to increase the melting temperature of the G-quadruplex by 2-20 degrees C at 1 microM dye concentration. This increase in T(m) value was well correlated with an increase in the efficiency of telomerase inhibition in vitro. The best telomerase inhibitor showed an IC(50) value of 28 nM in a standard telomerase repeat amplification protocol assay. Fluorescence energy transfer can thus be used to reveal the formation of four-stranded DNA structures, and its stabilization by quadruplex-binding agents, in an effort to discover new potent telomerase inhibitors. 相似文献